Show items per page
Elements: 252
Page 1 on 13
 TitleAuthors / EditorsDate
add to browser selection
HCV disease burden and population segments in Switzerland Bihl, Florian; Bruggmann, Philip; Castro Batänjer, Erika; Dufour, Jean-Francois; ... Blach, Sarah 2022
add to browser selection
Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis Correia De Sousa, Marta; Calo, Nicolas Virgile; Sobolewski, Cyril; Gjorgjieva, Monika; ... Foti, Michelangelo 2021
add to browser selection
The case for simplifying and using absolute targets for viral hepatitis elimination goals Polaris Observatory Collaborators 2021
add to browser selection
Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland Müllhaupt, Beat; Semela, David; Ruckstuhl, Lisa; Magenta, Lorenzo; ... Semmo, Nasser 2021
add to browser selection
Hepatitis C prevalence in the psychiatric setting: cost-effectiveness of scaling-up screening and direct-acting antiviral therapy Girardin, François; Painter, Chris; Hearmon, Natalie; Eddowes, Lucy; ... Vernaz-Hegi, Nathalie 2021
add to browser selection
Hepatitis C core antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis Sadeghimehr, Maryam; Bertisch, Barbara; Negro, Francesco; Butsashvili, Maia; ... Estill, Janne Anton Markus 2021
add to browser selection
HDV pathogenesis: unravelling ariadne's thread Tseligka, Eirini; Clément Leboube, Sophie; Negro, Francesco 2021
add to browser selection
Residual risk of liver disease after hepatitis C virus eradication Negro, Francesco 2021
add to browser selection
NAFLD and MAFLD as emerging causes of HCC: a populational study Myers, Shuna; Neyroud, Isabelle; Spahr, Laurent François Joséph; Gkouvatsos, Konstantinos; ... Goossens, Nicolas 2021
add to browser selection
Real-world outcomes in historically underserved patients with chronic hepatitis C infection treated with Glecaprevir/Pibrentasvir Aghemo, Alessio; Horsmans, Yves; Bourgeois, Stefan; Bondin, Mark; ... Lampertico, Pietro 2021
add to browser selection
The changing context of hepatitis D. Rizzetto, Mario; Hamid, Saeed; Negro, Francesco 2021
add to browser selection
Recommandations pour le suivi des patients atteints d'hépatite C guérie Bobzin, Carina; Bsiger, Christophe; Bruggmann, Philip; Cerny, Andreas; ... Thurnheer, Maria Christine 2021
add to browser selection
MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective Fouad, Yasser; Lazarus, Jeffrey V; Negro, Francesco; Peck-Radosavljevic, Markus; ... Colombo, Massimo 2021
add to browser selection
Maladies infectieuses Nguyen, Aude; Posfay Barbe, Klara; Blanchard Rohner, Géraldine; Buvelot, Hélène; ... Csaki Huttner, Angela 2021
add to browser selection
Endpoints and New Options for Treatment of Chronic Hepatitis D Lok, Anna S; Negro, Francesco; Asselah, Tarik; Farci, Patrizia; Rizzetto, Mario 2021
add to browser selection
Hepatitis C virus: current steps toward elimination in Germany and barriers to reaching the 2030 goal Sarrazin, Christoph; Boesecke, Christoph; Golsabahi-Broclawski, Solmaz; Moog, Gero; ... Wörns, Marcus-Alexander 2021
add to browser selection
The never-ending debate about conflict of interests' Negro, Francesco 2021
add to browser selection
EASL recommendations on treatment of hepatitis C: final update of the series European association for the study of the liver 2020
add to browser selection
Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis? Negro, Francesco 2020
add to browser selection
Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies Alfaiate, Dulce; Clement, Sophie; Rocha Gomes, Diana Bianca; Goossens, Nicolas; Negro, Francesco 2020
<< previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 ...12 | 13 |